Bradykinin b1 receptor antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 403/04 (2006.01) A61K 31/506 (2006.01) A61P 29/00 (2006.01) C07C 255/58 (2006.01) C07D 207/325 (2006.01) C07D 215/42 (2006.01) C07D 215/48 (2006.01) C07D 217/22 (2006.01) C07D 239/42 (2006.01) C07D 239/46 (2006.01) C07D 239/48 (2006.01) C07D 311/68 (2006.01) C07D 401/04 (2006.01) C07D 401/14 (2006.01) C07D 403/06 (2006.01) C07D 403/14 (2006.01) C07D 405/04 (2006.01) C07D 405/12 (2006.01) C07D 405/14 (2006.01) C07D 409/04 (2006.01) C07D 409/14 (2006.01) C07D 413/04 (2006.01) C07D 417/04 (2006.01) C07D 5

Patent

CA 2379064

Bradykinin B1 receptor antagonists of formula (I) are disclosed. The compounds are useful for treating diseases associated with inappropriate bradykinin receptor activity, such as diabetic vasculopathy, inflammation, pain, hyperalgesia, asthma, rhinitis, septic shock, atherosclerosis and multiple sclerosis. Pyrimidines, triazines, and anilines in which Q is imidazolyl or pyrrolyl are particularly preferred.

La présente invention concerne des antagonistes du récepteur B¿1? de la bradykinine représentés par la formule générale (I). Ces composés conviennent au traitement d'affections liées à la dysactivité du récepteur de la bradykinine, telles que vasculopathie diabétique, inflammation, douleur, hyperalgie, asthme, rhinite, choc septique, athérosclérose, et sclérose en plaques. On préfère particulièrement les pyrimidines, triazines, et anilines dans lesquelles Q est imidazolyle ou pyrrolyle.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Bradykinin b1 receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Bradykinin b1 receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bradykinin b1 receptor antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1771012

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.